` VLG (Venture Life Group PLC) vs FTSE All Share Index Comparison - Alpha Spread

VLG
vs
F
FTSE All Share Index

Over the past 12 months, VLG has significantly outperformed FTSE All Share Index, delivering a return of +65% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
VLG vs FTSE All Share Index

Loading
VLG
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VLG vs FTSE All Share Index

Loading
VLG
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
VLG vs FTSE All Share Index

Loading
VLG
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Venture Life Group PLC vs Peers

FTSE All Share Index
VLG
OR
ULVR
HINDUNILVR
HLN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Venture Life Group PLC
Glance View

Market Cap
78.8m GBX
Industry
Consumer products

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

VLG Intrinsic Value
123.38 GBX
Undervaluation 50%
Intrinsic Value
Price
Back to Top